Fenofibrate, troglitazone, and 15-deoxy-Δ12,14- prostaglandin J2 close KATP channels and induce insulin secretion

Journal of Pharmacology and Experimental Therapeutics

Volumn 310, Issue 3, 2004, Pages 1273-1280

  Shimomura, Kenju ^a,d   Shimizu, Hiroyuki ^a   Ikeda, Mizuho ^b   Okada, Shuichi ^a   Kakei, Masafumi ^c   Matsumoto, Shigeji ^b   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NIPPON DENTAL UNIVERSITY   (Japan)

^c AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CALCIUM ION; FENOFIBRATE; FENOFIBRIC ACID; GLIBENCLAMIDE; INSULIN; LIGAND; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POTASSIUM CHANNEL; TROGLITAZONE;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; HAMSTER; HORMONAL REGULATION; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PATCH CLAMP; POTASSIUM CURRENT; PRIORITY JOURNAL;

ANIMALS; BIOLOGICAL RESPONSE MODIFIERS; CHROMANS; CRICETINAE; INSULIN; MEMBRANE PROTEINS; POTASSIUM CHANNELS; PROCETOFEN; PROSTAGLANDIN D2; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 4243173683     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.067249     Document Type: Article

References (43)

1. + channels and insulin secretion: their role in health and disease. Diabetologia 42:903-919.
2. ATP channel closure. FEBS Lett 459:367-376.
3. Braissant O, Foufelle F, Scotto C, Dauca M, and Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-α, -β and -γ in the adult rat. Endocrinology 137:354-366.
4. Brunmair B, Gras F, Nescen S, Roden M, Wagner L, Waldhausl W, and Furnsinn C (2001) Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-γ-mediated changes in gene expression. Diabetes 50:2309-2315.
5. Caldwell J (1989) The biochemical pharmacology of fenofibrate. Cardiology 76:33-44.
6. ATP channels. Diabetes 45:1439-1445.
7. ATP channel subunits. Neuron 18:827-838.
8. + channels in pancreatic β-cells. Nature (Lond) 311:271-273.
9. Corton JC, Anderson SP, and Stauber A (2000) Central role of peroxisome proliferator-activated receptors in the actions of perexisome proliferators. Annu Rev Pharmacol Toxicol 40:491-518.
10. Edwards G and Weston AH (1993) The pharmacology of ATP-sensitive potassium channels. Annu Rev Pharmacol Toxicol 33:597-637.
11. 2. J Biol Chem 258:11713-11718.
12. 2. Prostaglandins 35:277-300.
13. Gribble FM, Tucker SJ, Seino S, and Ashcroft FM (1998) Tissue specificity of sulfonylureas. Diabetes 47:1412-1418.
14. ATP channel: molecular cloning expression and biological properties. Proc Natl Acad Sci USA 95:8387-8391.
15. Holness MJ, Smith ND, Greenwood GK, and Sugden MC (2003) Acute (24 h) activation of peroxisome proliferator-activated receptor-α (PPARα) reverses high-fat feeding-induced insulin hypersecretion in vivo and in perifused pancreatic islets. J Endocrinol 177:197-205.
16. KATP: an inward rectifier subunit plus the sulfonylurea receptor. Science (Wash DC) 270:1166-1170.
17. + channels. Neuron 16:1011-1017.
18. + channel. FEBS Lett 409:232-236.
19. + channel. J Biol Chem 271:24321-24324.
20. 2 induces synthesis of interleukin-8 by endothelial cells in a PPAR-γ-independent manner. Prostaglandins Other Lipid Mediat 66:165-177.
21. ATP channel modulation. J Physiol 545:501-507.
22. ATP channel formation by the sulphonylurea receptors SUR1 with Kir6.2 subunits in rat dorsal vagal neurons in situ. J Physiol 509:339-346.
23. 2 formed in human plasma. Proc Natl Acad Sci USA 81:1317-1321.
24. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83:813-819.
25. Lemberger T, Desvergne B, and Wahli W (1996) Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu Rev Cell Dev Biol 12:335-363.
26. + channels in pancreatic β-cells: role, regulation and potential as therapeutic targets. Diabetologia 46:1046-1062.
27. Masuda K, Okamoto Y, Tsuura Y, Kato S, Miura T, Tsuda K, Horikoshi H, Ishida H, and Seino Y (1995) Effects of troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide. Diabetologia 38:24-30.
28. Ogawa J, Takahashi S, Fujiwara T, Fukushige J, Hosokawa T, Izumi T, Kurakata S, and Horikoshi H (1999) Troglitazone can prevent development of type 1 diabetes induced by multiple low-dose streptozotocin in mice. Life Sci 65:1287-1296.
29. Ohtani K, Shimizu H, Sato N, and Mori M (1998) Troglitazone (CS-045) inhibits β-cell proliferation rate following stimulation of insulin secretion in HIT-T15 cells. Endocrinology 139:172-178.
30. 2+ influx. J Endocrinol 150:107-111.
31. Rorsman P (1997) The pancreatic beta-cell as a fuel sensor: an electrophysiologist's viewpoint. Diabetologia 40:487-495.
32. + currents in pancreatic β cells are regulated by intracellular ATP. Pflugers Arch 405:305-309.
33. Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, Karin M, and Santoro MG (2000) Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase. Nature (Lond) 403:103-108.
34. Sakura H, Ammala C, Smith PA, Gribble FM, and Ashcroft FM (1995) Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic β-cells, brain, heart and skeletal muscles. FEBS Lett 377:338-344.
35. Schwanstecher M, Brandt C, Behrends S, Schaupp U, and Panten U (1992) Effects of MgATP on pinacidil-induced displacement of glibenclamide from the sulfonylurea receptor in a pancreatic β-cell line and rat cerebral cortex. Br J Pharmacol 106:295-301.
36. Shibata H, Nii S, Kobayashi M, Izumi T, Maeda E, Sasahara K, Yamaguchi K, Morita A, and Nishiwaki A (1993) Phase I study of a new hypoglycemic agent CS-045 in healthy volunteers: safety and pharmacokinetics in single administration. J Clin Ther Med 9:1503-1518.
37. ATP channel complex. J Gen Physiol 110:655-664.
38. Sturgess NC, Ashford ML, Cook DL, and Hales CN (1985) The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 31:474-475.
39. Sturgess NC, Kozlowski RZ, Carrington CA, Hales CN, and Ashford ML (1988) Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. Br J Pharmacol 95:83-94.
40. Tordjman K, Stanley KM, Bernal-Mizrachi C, Leone TC, Coleman T, Kelly DP, and Semonkovich CF (2002) PPARα suppresses insulin secretion and induces UCP2 in insulinoma cells. J Lipid Res 43:936-943.
41. Virsolvy-Vergine A, Bruck M, Dufor M, Cauvin A, Lupo B, and Bataille D (1988) An endogenous ligand for the central sulfonylurea receptor. FEBS Lett 242:65-69.
42. 2 on cytokine signaling in pancreatic β-cells. Am J Physiol Endocrinol Metab 286:E329-336.
43. + channel. J Physiol 499:715-720.